EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-13.02%
202417.82%
202396.93%
2022-31.52%
2021187.16%
202025.69%
20191.82%
2018283.73%
2017-40.93%
2016-2.31%